Germany's Merck KGaA is investing $334 million to open a biopharmaceutical plant in Daejeon, South Korea, marking its largest life science investment in the Asia-Pacific region.
Germany's Merck KGaA has invested $334 million to open a biopharmaceutical plant in Daejeon, South Korea, marking its largest life science investment in the Asia-Pacific region. The 44,500-square-meter facility will produce critical materials for biopharmaceutical development and manufacturing, aiming to strengthen the supply chain for pharmaceutical companies in the region.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Bank of China Dubai Branch's RMB 2 billion Magnolia Bond listed on Nasdaq Dubai
-
2
Samsung Electronics is down 4.44% from its previous close, now trading at ₩231,250.
-
3
Binance has launched the "Earn Arena" limited-time event, offering an Annual Percentage Rate (APR) of up to 35%.
-
4
Tang Yu-hsien, Head of Asia Rates and FX Strategy at JPMorgan Private Bank, stated in an interview that after the recent sell-off, gold still faces further downside risks due to persistently thin liquidity and room for interest rates to rise.
-
5
OKX to discontinue spot margin trading in Futures mode
-
6
BNP Paribas CIB Chairman says European clients became more active last quarter, helping fuel a jump in revenue at the corporate and investment bank.
-
7
Global Mainstream Cryptocurrency Exchange Landscape and Characteristics Analysis
-
8
JPMorgan Asset Management China ETF reaches fundraising cap
-
9
Chinese refineries are sourcing crude oil from West Africa and Brazil, as falling long-haul freight costs reduce expenses, providing them with more supply options amid increasing competition for Russian crude.
-
10
Samsung Electronics fell 5.99% from its previous close, now trading at ₩227,500.
Markets Today
Recommended Reading



